Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolterodine ER vs IR in Overactive Bladder
NCT00139724Phase 3Completed
- Sponsor
- Viatris
- Start
- May 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolterodine in overactive bladder (OAB), sponsored by Viatris. Started May 2005; status: completed.
02
Drugs
tolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00139724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139724.